WO2016195526A1 - Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur - Google Patents

Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur Download PDF

Info

Publication number
WO2016195526A1
WO2016195526A1 PCT/RU2015/000349 RU2015000349W WO2016195526A1 WO 2016195526 A1 WO2016195526 A1 WO 2016195526A1 RU 2015000349 W RU2015000349 W RU 2015000349W WO 2016195526 A1 WO2016195526 A1 WO 2016195526A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
theanine
dogs
cats
tryptophan
Prior art date
Application number
PCT/RU2015/000349
Other languages
English (en)
Russian (ru)
Inventor
Людмила Борисовна ТИМИРОВА
Original Assignee
Людмила Борисовна ТИМИРОВА
Денисов Дмитрий Евгеньевич
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Людмила Борисовна ТИМИРОВА, Денисов Дмитрий Евгеньевич filed Critical Людмила Борисовна ТИМИРОВА
Priority to PCT/RU2015/000349 priority Critical patent/WO2016195526A1/fr
Publication of WO2016195526A1 publication Critical patent/WO2016195526A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention se rapporte à la médecine vétérinaire. L'invention concerne une composition apaisante ayant une action de diminution de l'excitation sexuelle chez les chiens et les chats qui contient dans une dose pour 10 kg en poids du corps de l'animal, de 5 à 100 mg de théanine et de 2 à 16 mg de tryptophane. Cette composition normalise le comportement des animaux dans les 30 à 60 minutes suivant l'absorption.
PCT/RU2015/000349 2015-06-03 2015-06-03 Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur WO2016195526A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/RU2015/000349 WO2016195526A1 (fr) 2015-06-03 2015-06-03 Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2015/000349 WO2016195526A1 (fr) 2015-06-03 2015-06-03 Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur

Publications (1)

Publication Number Publication Date
WO2016195526A1 true WO2016195526A1 (fr) 2016-12-08

Family

ID=57441297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2015/000349 WO2016195526A1 (fr) 2015-06-03 2015-06-03 Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur

Country Status (1)

Country Link
WO (1) WO2016195526A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080044499A1 (en) * 2004-04-06 2008-02-21 Taiyokagaku Co., Ltd. Sleep Improvement Composition
RU2479316C2 (ru) * 2007-09-04 2013-04-20 Дзе Проктер Энд Гэмбл Компани Пероральные композиции, продукты и способы применения

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080044499A1 (en) * 2004-04-06 2008-02-21 Taiyokagaku Co., Ltd. Sleep Improvement Composition
RU2479316C2 (ru) * 2007-09-04 2013-04-20 Дзе Проктер Энд Гэмбл Компани Пероральные композиции, продукты и способы применения

Similar Documents

Publication Publication Date Title
KR101230977B1 (ko) 동물 식품 첨가제로서 이용되는 구아니디노 아세트산
JP5112865B2 (ja) ヘモグロビン尿症またはミオグロビン尿症の予防または治療用組成物
US8722115B2 (en) Methods for improving health in animals
US20100105867A1 (en) Process for producing osteocalcin-containing extract
KR20080110814A (ko) 리보플라빈과 세사민류를 함유하는 조성물
US20200390793A1 (en) Compositions and methods using oleuropein or curcumin for muscle quality and/or muscle mass
US20080014273A1 (en) Equine whole food supplements
EP3133935B1 (fr) Utilisation d'un extrait de scutellaria baicalensis comprenant de la baïcaline pendant la période de mise bas pour stimuler la lactation chez des animaux d'élevage.
WO2017119481A1 (fr) Composition contenant un dipeptide cyclique pour la prévention de maladie neurologiques
CN107530385A (zh) 用于促进脑源性神经营养因子产生的组合物
RU2543341C2 (ru) Успокаивающая композиция, понижающая возбудимость при половой охоте у кошек и собак
WO2016195526A1 (fr) Composition apaisante réduisant l'excitabilité des chats et des chiens en chaleur
RU2549496C1 (ru) Гомеопатическое лекарственное средство, оказывающее стресспротективное и ростостимулирующее действие, регулирующее обмен веществ у молодняка сельскохозяйственных животных и птицы
RU2671635C1 (ru) Состав для стимуляции иммунометаболических процессов и профилактики диарейного синдрома новорожденных телят
JP6671367B2 (ja) 環状ジペプチド含有抗肥満用組成物
RU2774770C1 (ru) Способ повышения привесов при одновременной профилактике оксидативного стресса у цыплят-бройлеров
RU2203557C1 (ru) Способ стимуляции воспроизводительных функций пушных зверей
WO2008035925A1 (fr) Composition alimentaire d'extrait de feuilles de pinus koraiensis à activité antioxydante
TW201713357A (zh) 抗肥胖用組成物
JP6280356B2 (ja) 育毛・発毛促進用経口剤
RU151345U1 (ru) Диетическая добавка с лечебно-профилактическими свойствами "фитокальцемин"
EP3284472B1 (fr) Agent supprimant les bouffées de chaleur
HALOUZKOVÁ et al. THE EFFECT OF PHYTOGENIC ADDITIVES ON HEALTH PARAMETERS IN RABBITS
CA3216989A1 (fr) Compositions nutritionnelles pour la conservation de la masse musculaire
KR20200029156A (ko) 황 함유아미노산 및 이의 복합제를 포함하는 바이러스 감염성 간 질환 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15894377

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15894377

Country of ref document: EP

Kind code of ref document: A1